SCHEMBL1800007

SCHEMBL1800007

CN(CC(=O)Nc1ccc(Cl)cc1)CC(=O)Nc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.64
ALOX12 P18054 1/20 0.64
ALDH1A1 P00352 9/20 0.63
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
LMNA P02545 1/20 0.63
HTT P42858 1/20 0.63
MAPT P10636 3/20 0.57
KDM4E B2RXH2 5/20 0.56
HSD17B10 Q99714 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
NPC1 O15118 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.51
GAA P10253 1/20 0.50
NPSR1 Q6W5P4 1/20 0.49
POLB P06746 1/20 0.49
GRIK1 P39086 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1796902 0.88 TP53 (0.65) TP53ALOX12ALDH1A1MEN1KMT2A
SCHEMBL1797318 0.83 ALDH1A1 (0.60) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL1797569 0.82 SERPINE1 (0.56) TP53ALDH1A1MEN1KMT2AMAPT
SCHEMBL1799375 0.81 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AMAPTKDM4E
Hydrochloric Acid SCHEMBL1800403 0.80 ALDH1A1 (0.57) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL1796237 0.79 ALDH1A1 (0.54) TP53ALOX12ALDH1A1MEN1KMT2A
SCHEMBL7528165 0.76 KDM4E (0.71) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL27331760 0.76 KDM4E (0.66) TP53ALDH1A1MEN1KMT2AMAPT
SCHEMBL418999 0.76 KDM4E (0.66) TP53ALDH1A1MEN1KMT2AMAPT
SCHEMBL18180823 0.76 SERPINE1 (0.65) ALDH1A1MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US claimed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US claimed
EP-2990057-A1 NOVEL USE FOR PAI-1 INHIBITOR Renascience Co., Ltd. (JP) 2016-03-02 EP disclosed
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 TP53 2527/4885ALOX12 1212/4885ALDH1A1 800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.